Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Geminal Coordinatively Unsaturated Sites on MOF-808 for the Selective Uptake of Phenolics from a Real Bio-Oil Mixture.

Jia C, Cirujano FG, Bueken B, Claes B, Jonckheere D, Van Geem KM, De Vos D.

ChemSusChem. 2019 Mar 21;12(6):1256-1266. doi: 10.1002/cssc.201802692. Epub 2019 Feb 27.

PMID:
30810285
2.

An antibiofilm coating of 5-aryl-2-aminoimidazole covalently attached to a titanium surface.

Peeters E, Hooyberghs G, Robijns S, De Weerdt A, Kucharíková S, Tournu H, Braem A, Čeh K, Majdič G, Španič T, Pogorevc E, Claes B, Dovgan B, Girandon L, Impellizzeri F, Erdtmann M, Krona A, Vleugels J, Fröhlich M, Garcia-Forgas J, De Brucker K, Cammue BPA, Thevissen K, Van Dijck P, Vanderleyden J, Van der Eycken E, Steenackers HP.

J Biomed Mater Res B Appl Biomater. 2019 Aug;107(6):1908-1919. doi: 10.1002/jbm.b.34283. Epub 2018 Dec 13.

PMID:
30549192
3.

Specific Lipid and Metabolic Profiles of R-CHOP-Resistant Diffuse Large B-Cell Lymphoma Elucidated by Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging and in Vivo Imaging.

Barré FPY, Claes BSR, Dewez F, Peutz-Kootstra C, Munch-Petersen HF, Grønbæk K, Lund AH, Heeren RMA, Côme C, Cillero-Pastor B.

Anal Chem. 2018 Dec 18;90(24):14198-14206. doi: 10.1021/acs.analchem.8b02910. Epub 2018 Dec 4.

4.

Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia.

Colijn JM, den Hollander AI, Demirkan A, Cougnard-Grégoire A, Verzijden T, Kersten E, Meester-Smoor MA, Merle BMJ, Papageorgiou G, Ahmad S, Mulder MT, Costa MA, Benlian P, Bertelsen G, Bron AM, Claes B, Creuzot-Garcher C, Erke MG, Fauser S, Foster PJ, Hammond CJ, Hense HW, Hoyng CB, Khawaja AP, Korobelnik JF, Piermarocchi S, Segato T, Silva R, Souied EH, Williams KM, van Duijn CM, Delcourt C, Klaver CCW; European Eye Epidemiology Consortium; EYE-RISK Consortium.

Ophthalmology. 2019 Mar;126(3):393-406. doi: 10.1016/j.ophtha.2018.09.045. Epub 2018 Oct 10.

PMID:
30315903
5.

Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice.

Sherwood JL, Brown H, Rettino A, Schreieck A, Clark G, Claes B, Agrawal B, Chaston R, Kong BSG, Choppa P, Nygren AOH, Deras IL, Kohlmann A.

ESMO Open. 2017 Sep 28;2(4):e000235. doi: 10.1136/esmoopen-2017-000235. eCollection 2017. Erratum in: ESMO Open. 2018 Jan 3;3(1):e000235corr1.

6.

Adsorption and Separation of Aromatic Amino Acids from Aqueous Solutions Using Metal-Organic Frameworks.

Jonckheere D, Steele JA, Claes B, Bueken B, Claes L, Lagrain B, Roeffaers MBJ, De Vos DE.

ACS Appl Mater Interfaces. 2017 Sep 6;9(35):30064-30073. doi: 10.1021/acsami.7b09175. Epub 2017 Aug 22.

PMID:
28782925
7.

Smart Metal-Organic Framework Coatings: Triggered Antibiofilm Compound Release.

Claes B, Boudewijns T, Muchez L, Hooyberghs G, Van der Eycken EV, Vanderleyden J, Steenackers HP, De Vos DE.

ACS Appl Mater Interfaces. 2017 Feb 8;9(5):4440-4449. doi: 10.1021/acsami.6b14152. Epub 2017 Jan 24.

PMID:
28081368
8.

BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System.

Janku F, Huang HJ, Claes B, Falchook GS, Fu S, Hong D, Ramzanali NM, Nitti G, Cabrilo G, Tsimberidou AM, Naing A, Piha-Paul SA, Wheler JJ, Karp DD, Holley VR, Zinner RG, Subbiah V, Luthra R, Kopetz S, Overman MJ, Kee BK, Patel S, Devogelaere B, Sablon E, Maertens G, Mills GB, Kurzrock R, Meric-Bernstam F.

Mol Cancer Ther. 2016 Jun;15(6):1397-404. doi: 10.1158/1535-7163.MCT-15-0712. Epub 2016 May 20.

9.

BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.

Janku F, Claes B, Huang HJ, Falchook GS, Devogelaere B, Kockx M, Bempt IV, Reijans M, Naing A, Fu S, Piha-Paul SA, Hong DS, Holley VR, Tsimberidou AM, Stepanek VM, Patel SP, Kopetz ES, Subbiah V, Wheler JJ, Zinner RG, Karp DD, Luthra R, Roy-Chowdhuri S, Sablon E, Meric-Bernstam F, Maertens G, Kurzrock R.

Oncotarget. 2015 Sep 29;6(29):26886-94. doi: 10.18632/oncotarget.4723.

10.

Knowledge and management of endotracheal tube cuffs.

Labeau SO, Bleiman M, Rello J, Vandijck DM, Claes B, Blot SI.

Int J Nurs Stud. 2015 Jan;52(1):498-9. doi: 10.1016/j.ijnurstu.2014.09.010. Epub 2014 Oct 5. No abstract available.

PMID:
25445032
11.

Influence of dietary macronutrient composition on eating behaviour and self-perception in young women undergoing weight management.

Cheng HL, Griffin H, Claes BE, Petocz P, Steinbeck K, Rooney K, O'Connor H.

Eat Weight Disord. 2014 Jun;19(2):241-7. doi: 10.1007/s40519-014-0110-y. Epub 2014 Mar 8.

PMID:
24609724
12.

Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab.

Smith CG, Fisher D, Claes B, Maughan TS, Idziaszczyk S, Peuteman G, Harris R, James MD, Meade A, Jasani B, Adams RA, Kenny S, Kaplan R, Lambrechts D, Cheadle JP.

Clin Cancer Res. 2013 Aug 1;19(15):4104-13. doi: 10.1158/1078-0432.CCR-12-2581. Epub 2013 Jun 5.

13.

Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancer.

Loi S, Michiels S, Lambrechts D, Fumagalli D, Claes B, Kellokumpu-Lehtinen PL, Bono P, Kataja V, Piccart MJ, Joensuu H, Sotiriou C.

J Natl Cancer Inst. 2013 Jul 3;105(13):960-7. doi: 10.1093/jnci/djt121. Epub 2013 Jun 5.

14.

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.

Beuselinck B, Karadimou A, Lambrechts D, Claes B, Wolter P, Couchy G, Berkers J, Paridaens R, Schöffski P, Méjean A, Verkarre V, Lerut E, de la Taille A, Tourani JM, Bigot P, Linassier C, Négrier S, Berger J, Patard JJ, Zucman-Rossi J, Oudard S.

Br J Cancer. 2013 Mar 5;108(4):887-900. doi: 10.1038/bjc.2012.548.

15.

VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib - a multicentric retrospective analysis.

Beuselinck B, Karadimou A, Lambrechts D, Claes B, Wolter P, Couchy G, Berkers J, van Poppel H, Paridaens R, Schöffski P, Méjean A, Verkarre V, Lerut E, Joly F, Lebret T, Gravis G, Deplanque G, Descazeaud A, Leclercq NR, Molinié V, Patard JJ, Teghom C, Elaidi R, Zucman-Rossi J, Oudard S.

Acta Oncol. 2014 Jan;53(1):103-12. doi: 10.3109/0284186X.2013.770600. Epub 2013 Feb 20.

PMID:
23421954
16.

High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.

Garcia-Dios DA, Lambrechts D, Coenegrachts L, Vandenput I, Capoen A, Webb PM, Ferguson K; ANECS, Akslen LA, Claes B, Vergote I, Moerman P, Van Robays J, Marcickiewicz J, Salvesen HB, Spurdle AB, Amant F.

Gynecol Oncol. 2013 Feb;128(2):327-34. doi: 10.1016/j.ygyno.2012.11.037. Epub 2012 Dec 4.

PMID:
23219661
17.

Comprehensive mutation analysis in colorectal flat adenomas.

Voorham QJ, Carvalho B, Spiertz AJ, Claes B, Mongera S, van Grieken NC, Grabsch H, Kliment M, Rembacken B, van de Wiel MA, Quirke P, Mulder CJ, Lambrechts D, van Engeland M, Meijer GA.

PLoS One. 2012;7(7):e41963. doi: 10.1371/journal.pone.0041963. Epub 2012 Jul 27.

18.

VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials.

Lambrechts D, Claes B, Delmar P, Reumers J, Mazzone M, Yesilyurt BT, Devlieger R, Verslype C, Tejpar S, Wildiers H, de Haas S, Carmeliet P, Scherer SJ, Van Cutsem E.

Lancet Oncol. 2012 Jul;13(7):724-33. doi: 10.1016/S1470-2045(12)70231-0. Epub 2012 May 17.

PMID:
22608783
19.

Adverse drug events in intensive care units: a cross-sectional study of prevalence and risk factors.

Seynaeve S, Verbrugghe W, Claes B, Vandenplas D, Reyntiens D, Jorens PG.

Am J Crit Care. 2011 Nov;20(6):e131-40. doi: 10.4037/ajcc2011818.

20.

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Maughan TS, Adams RA, Smith CG, Meade AM, Seymour MT, Wilson RH, Idziaszczyk S, Harris R, Fisher D, Kenny SL, Kay E, Mitchell JK, Madi A, Jasani B, James MD, Bridgewater J, Kennedy MJ, Claes B, Lambrechts D, Kaplan R, Cheadle JP; MRC COIN Trial Investigators.

Lancet. 2011 Jun 18;377(9783):2103-14. doi: 10.1016/S0140-6736(11)60613-2. Epub 2011 Jun 5.

21.

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, Apicella C, Smith LD, Hammet F, Southey MC, Van 't Veer LJ, de Groot R, Smit VT, Fasching PA, Beckmann MW, Jud S, Ekici AB, Hartmann A, Hein A, Schulz-Wendtland R, Burwinkel B, Marme F, Schneeweiss A, Sinn HP, Sohn C, Tchatchou S, Bojesen SE, Nordestgaard BG, Flyger H, Ørsted DD, Kaur-Knudsen D, Milne RL, Pérez JI, Zamora P, Rodríguez PM, Benítez J, Brauch H, Justenhoven C, Ko YD; Genica Network, Hamann U, Fischer HP, Brüning T, Pesch B, Chang-Claude J, Wang-Gohrke S, Bremer M, Karstens JH, Hillemanns P, Dörk T, Nevanlinna HA, Heikkinen T, Heikkilä P, Blomqvist C, Aittomäki K, Aaltonen K, Lindblom A, Margolin S, Mannermaa A, Kosma VM, Kauppinen JM, Kataja V, Auvinen P, Eskelinen M, Soini Y, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Holland H; kConFab; AOCS, Lambrechts D, Claes B, Vandorpe T, Neven P, Wildiers H, Flesch-Janys D, Hein R, Löning T, Kosel M, Fredericksen ZS, Wang X, Giles GG, Baglietto L, Severi G, McLean C, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Alnæs GG, Kristensen V, Børresen-Dale AL, Hunter DJ, Hankinson SE, Andrulis IL, Mulligan AM, O'Malley FP, Devilee P, Huijts PE, Tollenaar RA, Van Asperen CJ, Seynaeve CS, Chanock SJ, Lissowska J, Brinton L, Peplonska B, Figueroa J, Yang XR, Hooning MJ, Hollestelle A, Oldenburg RA, Jager A, Kriege M, Ozturk B, van Leenders GJ, Hall P, Czene K, Humphreys K, Liu J, Cox A, Connley D, Cramp HE, Cross SS, Balasubramanian SP, Reed MW, Dunning AM, Easton DF, Humphreys MK, Caldas C, Blows F, Driver K, Provenzano E, Lubinski J, Jakubowska A, Huzarski T, Byrski T, Cybulski C, Gorski B, Gronwald J, Brennan P, Sangrajrang S, Gaborieau V, Shen CY, Hsiung CN, Yu JC, Chen ST, Hsu GC, Hou MF, Huang CS, Anton-Culver H, Ziogas A, Pharoah PD, Garcia-Closas M.

Hum Mol Genet. 2011 Aug 15;20(16):3289-303. doi: 10.1093/hmg/ddr228. Epub 2011 May 19.

22.

Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the Muenster Aging and Retina Study (MARS).

Dietzel M, Zeimer M, Heimes B, Claes B, Pauleikhoff D, Hense HW.

Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3452-7. doi: 10.1167/iovs.10-6713.

PMID:
21296816
23.

Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs.

Smeets A, Daemen A, Vanden Bempt I, Gevaert O, Claes B, Wildiers H, Drijkoningen R, Van Hummelen P, Lambrechts D, De Moor B, Neven P, Sotiriou C, Vandorpe T, Paridaens R, Christiaens MR.

Breast Cancer Res Treat. 2011 Oct;129(3):767-76. doi: 10.1007/s10549-010-1265-5. Epub 2010 Nov 30.

PMID:
21116709
24.

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

De Roock W, Claes B, Bernasconi D, De Schutter J, Biesmans B, Fountzilas G, Kalogeras KT, Kotoula V, Papamichael D, Laurent-Puig P, Penault-Llorca F, Rougier P, Vincenzi B, Santini D, Tonini G, Cappuzzo F, Frattini M, Molinari F, Saletti P, De Dosso S, Martini M, Bardelli A, Siena S, Sartore-Bianchi A, Tabernero J, Macarulla T, Di Fiore F, Gangloff AO, Ciardiello F, Pfeiffer P, Qvortrup C, Hansen TP, Van Cutsem E, Piessevaux H, Lambrechts D, Delorenzi M, Tejpar S.

Lancet Oncol. 2010 Aug;11(8):753-62. doi: 10.1016/S1470-2045(10)70130-3. Epub 2010 Jul 8.

PMID:
20619739
25.

Pharmaco-epigenomics: discovering therapeutic approaches and biomarkers for cancer therapy.

Claes B, Buysschaert I, Lambrechts D.

Heredity (Edinb). 2010 Jul;105(1):152-60. doi: 10.1038/hdy.2010.42. Epub 2010 Apr 14. Review.

26.

An evaluation of family-centered care services and organization of visiting policies in Belgian intensive care units: a multicenter survey.

Vandijck DM, Labeau SO, Geerinckx CE, De Puydt E, Bolders AC, Claes B, Blot SI; Executive Board of the Flemish Society for Critical Care Nurses, Ghent and Edegem, Belgium.

Heart Lung. 2010 Mar-Apr;39(2):137-46. doi: 10.1016/j.hrtlng.2009.06.001. Epub 2009 Jul 22.

PMID:
20207274
27.

Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene.

Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, Coolen J, Mathieu C, Decramer M, Lambrechts D.

Thorax. 2010 Mar;65(3):215-20. doi: 10.1136/thx.2009.120659. Epub 2009 Dec 8.

PMID:
19996341
28.

Nurses' knowledge of evidence-based guidelines for the prevention of surgical site infection.

Labeau SO, Witdouck SS, Vandijck DM, Claes B, Rello J, Vandewoude KH, Lizy CM, Vogelaers DP, Blot SI; Executive Board of the Flemish Society for Critical Care Nurses.

Worldviews Evid Based Nurs. 2010 Mar;7(1):16-24. doi: 10.1111/j.1741-6787.2009.00177.x. Epub 2009 Nov 16.

PMID:
19919658
29.

Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM.

N Engl J Med. 2009 Jul 23;361(4):345-57. doi: 10.1056/NEJMoa0810739.

30.

Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users.

Dieudonné AS, Lambrechts D, Claes B, Vandorpe T, Wildiers H, Timmerman D, Billen J, Leunen K, Amant F, Berteloot P, Smeets A, Paridaens R, Weltens C, Van Limbergen E, Van den Bogaert W, Vergote I, Van Huffel S, Christiaens MR, Neven P.

Breast Cancer Res Treat. 2009 Dec;118(3):531-8. doi: 10.1007/s10549-009-0463-5. Epub 2009 Jul 12.

PMID:
19597703
31.

PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer.

Prenen H, De Schutter J, Jacobs B, De Roock W, Biesmans B, Claes B, Lambrechts D, Van Cutsem E, Tejpar S.

Clin Cancer Res. 2009 May 1;15(9):3184-8. doi: 10.1158/1078-0432.CCR-08-2961. Epub 2009 Apr 14.

32.

Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration.

Poesen K, Lambrechts D, Van Damme P, Dhondt J, Bender F, Frank N, Bogaert E, Claes B, Heylen L, Verheyen A, Raes K, Tjwa M, Eriksson U, Shibuya M, Nuydens R, Van Den Bosch L, Meert T, D'Hooge R, Sendtner M, Robberecht W, Carmeliet P.

J Neurosci. 2008 Oct 15;28(42):10451-9. doi: 10.1523/JNEUROSCI.1092-08.2008.

33.

Critical care nurses' knowledge of evidence-based guidelines for preventing infections associated with central venous catheters: an evaluation questionnaire.

Labeau S, Vereecke A, Vandijck DM, Claes B, Blot SI; executive board of the Flemish Society for Critical Care Nurses.

Am J Crit Care. 2008 Jan;17(1):65-71; quiz 72.

34.

Undergraduate nursing students' knowledge and perception of infection prevention and control.

Vandijck DM, Labeau SO, De Somere J, Claes B, Blot SI; Executive Board of the Flemish Society of Critical Care Nurses.

J Hosp Infect. 2008 Jan;68(1):92-4. Epub 2007 Dec 11. No abstract available.

PMID:
18063197
35.

Critical care nurses' knowledge of evidence-based guidelines for preventing ventilator-associated pneumonia: an evaluation questionnaire.

Labeau S, Vandijck DM, Claes B, Van Aken P, Blot SI; executive board of the Flemish Society for Critical Care Nurses.

Am J Crit Care. 2007 Jul;16(4):371-7.

36.

Evidence-based guidelines for the prevention of ventilator-associated pneumonia: results of a knowledge test among intensive care nurses.

Blot SI, Labeau S, Vandijck D, Van Aken P, Claes B; Executive Board of the Flemish Society for Critical Care Nurses.

Intensive Care Med. 2007 Aug;33(8):1463-7. Epub 2007 Jun 1.

PMID:
17541752
37.

Modeling smoking history: a comparison of different approaches in the MARS study on age-related maculopathy.

Neuner B, Wellmann J, Dasch B, Behrens T, Claes B, Dietzel M, Pauleikhoff D, Hense HW.

Ann Epidemiol. 2007 Aug;17(8):615-21. Epub 2007 May 25.

PMID:
17531503
38.

[Two-and three-dimensional reconstructions in creating the Photofit].

Claes B, Clauwaert P.

Rev Belge Med Dent (1984). 2005;60(3):250-3. French.

PMID:
16370440
39.

The expression of the salt-responsive gene salT from rice is regulated by hormonal and developmental cues.

Garcia AB, Engler Jde A, Claes B, Villarroel R, Van Montagu M, Gerats T, Caplan A.

Planta. 1998 Dec;207(2):172-80.

PMID:
9951720
40.

Clonidine added to bupivacaine-epinephrine-sufentanil improves epidural analgesia during childbirth.

Claes B, Soetens M, Van Zundert A, Datta S.

Reg Anesth Pain Med. 1998 Nov-Dec;23(6):540-7.

PMID:
9840847
41.

Heat-inducible rice hsp82 and hsp70 are not always co-regulated.

Van Breusegem F, Dekeyser R, Garcia AB, Claes B, Gielen J, Van Montagu M, Caplan AB.

Planta. 1994;193(1):57-66.

PMID:
7764623
42.

Organ-dependent regulation of a plant promoter isolated from rice by 'promoter-trapping' in tobacco.

Claes B, Smalle J, Dekeyser R, Van Montagu M, Caplan A.

Plant J. 1991 Jul;1(1):15-26.

43.

Flavomycin effects on performance of beef bulls and nutrient digestibility in wethers.

De Schrijver R, Fremaut D, Claes B.

Dtsch Tierarztl Wochenschr. 1991 Feb;98(2):47-50.

PMID:
2026115
44.

Transient Gene Expression in Intact and Organized Rice Tissues.

Dekeyser RA, Claes B, De Rycke R, Habets ME, Van Montagu MC, Caplan AB.

Plant Cell. 1990 Jul;2(7):591-602.

45.

Characterization of a rice gene showing organ-specific expression in response to salt stress and drought.

Claes B, Dekeyser R, Villarroel R, Van den Bulcke M, Bauw G, Van Montagu M, Caplan A.

Plant Cell. 1990 Jan;2(1):19-27.

46.

Evaluation of selectable markers for rice transformation.

Dekeyser R, Claes B, Marichal M, Van Montagu M, Caplan A.

Plant Physiol. 1989 May;90(1):217-23.

47.

[Ileo-ureteral reflux after urinary diversion through an ileal conduit].

van Poppel H, Vereecken RL, Verduyn H, D'hoedt M, Claes B.

Urologe A. 1983 Nov;22(6):446-9. German.

PMID:
6686373

Supplemental Content

Support Center